User profiles for Neeraj Narula

Neeraj Narula

McMaster University
Verified email at medportal.ca
Cited by 6297

Loss of response to anti-TNFs: definition, epidemiology, and management

G Roda, B Jharap, N Neeraj… - Clinical and translational …, 2016 - journals.lww.com
Tumor necrosis factor-α (TNFα) antagonists have advanced the management of inflammatory
bowel diseases patients leading to an improvement of patient's quality of life with the …

Enteral nutritional therapy for induction of remission in Crohn's disease

N Narula, A Dhillon, D Zhang… - Cochrane database …, 2018 - cochranelibrary.com
Background Corticosteroids are often preferred over enteral nutrition (EN) as induction therapy
for Crohn's disease (CD). Prior meta‐analyses suggest that corticosteroids are superior …

Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study

N Narula, ECL Wong, M Dehghan, A Mente… - Bmj, 2021 - bmj.com
Objective To evaluate the relation between intake of ultra-processed food and risk of
inflammatory bowel disease (IBD). Design Prospective cohort study. Setting 21 low, middle, and …

Management strategies to improve outcomes of patients with inflammatory bowel diseases

JF Colombel, N Narula, L Peyrin-Biroulet - Gastroenterology, 2017 - Elsevier
Strategies for management of inflammatory bowel diseases are shifting from simple control
of symptoms toward full control of these diseases (clinical and endoscopic remission), with …

Mucosal healing is associated with improved long-term outcomes of patients with ulcerative colitis: a systematic review and meta-analysis

SC Shah, JF Colombel, BE Sands, N Narula - Clinical gastroenterology and …, 2016 - Elsevier
Background & Aims The paradigm for treatment for ulcerative colitis (UC) is shifting from
resolving symptoms toward objective measures such as mucosal healing (MH). However, it is …

The real-world effectiveness and safety of vedolizumab for moderate–severe Crohn's disease: results from the US VICTORY Consortium

…, S Singh, X Jiang, F Peerani, N Narula… - Official journal of the …, 2016 - journals.lww.com
… Dulai, Parambir S MD 1 ; Singh, Siddharth MD, MS 1,2 ; Jiang, Xiaoqian PhD 2 ; Peerani,
Farhad MD 3 ; Narula, Neeraj MD 3 ; Chaudrey, Khadija MD 4 ; Whitehead, Diana MD 5 ; …

Systematic review and meta-analysis: fecal microbiota transplantation for treatment of active ulcerative colitis

N Narula, Z Kassam, Y Yuan… - Inflammatory bowel …, 2017 - academic.oup.com
Background Changes in the colonic microbiota may play a role in the pathogenesis of
ulcerative colitis (UC) and restoration of healthy gut microbiota may ameliorate disease. A …

Systematic review and meta-analysis: infliximab or cyclosporine as rescue therapy in patients with severe ulcerative colitis refractory to steroids

N Narula, JK Marshall, JF Colombel… - Official journal of the …, 2016 - journals.lww.com
OBJECTIVES: Acute severe steroid-refractory ulcerative colitis (UC) carries a poor prognosis
and requires optimal management. A systematic review and meta-analysis were conducted …

Open: Vedolizumab for ulcerative colitis: treatment outcomes from the VICTORY consortium

N Narula, F Peerani, J Meserve… - Official journal of the …, 2018 - journals.lww.com
OBJECTIVES: We aimed to quantify the safety and effectiveness of vedolizumab (VDZ) when
used for UC, and to identify predictors of response to treatment. METHODS: Retrospective …

Food processing and risk of inflammatory bowel disease: a systematic review and meta-analysis

N Narula, NH Chang, D Mohammad, ECL Wong… - Clinical …, 2023 - Elsevier
Background & Aims Several studies have been published on the association between food
processing and risks of Crohn’s disease (CD) and ulcerative colitis (UC), with some …